Domov › Velika depresivna motnja › Maryland
Klinične študije za Velika depresivna motnja v Maryland
21 študij za Velika depresivna motnja išče udeležence na lokacijah v Maryland.
Mesta v Maryland
Uradno besedilo študije (angleško)
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 8–70 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05669703Natural History of Depression, Bipolar Disorder and Suicide Risk
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študija
Starost 18–120 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06462196A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07573176Characterization and Treatment of Adolescent Depression
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 11–25 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT03388606A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Delricht Research - Rockville, Rockville
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07621237A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Johns Hopkins University, Baltimore
Vključevanje udeležencevFaza 3
Starost 12–17 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Sunstone Medical, PC, Rockville
Vključevanje udeležencevFaza 3
Starost 18–85 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06793397Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevFaza 1Vabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT03065335Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- National Institutes of Health Clinical Center, Bethesda
- University of Maryland, College Park, College Park
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
Starost 8–65 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT00018057Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevFaza 2
Starost 18–70 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06511908Defining Neurobiological Links Between Substance Use and Mental Illness
- National Institute on Drug Abuse, Baltimore
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–60 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT05538910Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevFaza 1
Starost 18–70 · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT03973268Neurobiology of Suicide
- National Institutes of Health Clinical Center, Bethesda
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
Starost 18–70 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT02543983A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Pharmasite Research Inc., Baltimore
Vključevanje udeležencevFaza 3
Starost 18–74 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Gaithersburg
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 26. avg. 2026 · NCT07300969A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT07412756A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Continental Clinical Solutions, Towson
Vključevanje udeležencevFaza 2
Starost 18–64 · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT07115329Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Gaithersburg
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Pikesville
Vključevanje udeležencevFaza 3
Starost 18–65 · Vsi spoli · Posodobljeno 24. jul. 2026 · NCT07484217A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Sheppard Pratt, Baltimore
- Sunstone Medical, PC, Rockville
Vključevanje udeležencevFaza 2
Starost 18–65 · Vsi spoli · Posodobljeno 11. maj 2026 · NCT06524830Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.